PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model: Molecular Therapy - Oncolytics
News: CAST-Seq: A New and Much-Needed Tool for Assessing the Safety of Designer Nucleases - CRISPR Medicine
Cellectis' Innovation Days event highlighted New Product
Team:Freiburg/HP/Gold Integrated - 2017.igem.org
Cancers | Free Full-Text | An Anti-PSMA Immunotoxin Reduces Mcl-1 and Bcl2A1 and Specifically Induces in Combination with the BAD-Like BH3 Mimetic ABT-737 Apoptosis in Prostate Cancer Cells
Cathomen — Faculty of Medicine
Team:Freiburg/HP/Gold Integrated - 2017.igem.org
CMN Webinar - CRISPR Off-Targets , June 23rd 2021
Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells: Molecular Therapy - Methods & Clinical Development
Automated generation of gene-edited CAR T cells at clinical scale. - Abstract - Europe PMC
The RESTORE Momentum Workshop - RESTORE
Automated generation of gene-edited CAR T cells at clinical scale: Molecular Therapy - Methods & Clinical Development
Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells: Molecular Therapy - Methods & Clinical Development
e-School
New Frontiers for Patient Care: The Intersection of Inherited Disease, Gene Therapy, and HSCT
IJMS | Free Full-Text | Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient in vitro Clearance of iPSCs and iPSC-Macrophages
IJMS | Free Full-Text | Chimerization Enables Gene Synthesis and Lentiviral Delivery of Customizable TALE-Based Effectors | HTML
Annual Biomedical Scientific Congress at NUS - Posts | Facebook
Streptococcus thermophilus CRISPR-Cas9 Systems Enable Specific Editing of the Human Genome: Molecular Therapy
News: CAST-Seq: A New and Much-Needed Tool for Assessing the Safety of Designer Nucleases - CRISPR Medicine
Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells: Molecular Therapy - Methods & Clinical Development
Regenerative medicine: curing rather than simply treating diseases - Healthcare industry
News: CAST-Seq: A New and Much-Needed Tool for Assessing the Safety of Designer Nucleases - CRISPR Medicine
Viruses | Free Full-Text | Improved Specificity and Safety of Anti-Hepatitis B Virus TALENs Using Obligate Heterodimeric FokI Nuclease Domains
JPM | Free Full-Text | Efficient Genetic Safety Switches for Future Application of iPSC-Derived Cell Transplants | HTML